Synthroid
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0074-4341 -
Package NDC
0074-4341-19 -
Package NDC
0074-4341-72 -
Package NDC
0074-4341-90 -
Application number
NDA021402 -
SPL ID
b85ab7fa-ba96-43cd-b736-44b3924e644c -
SPL set ID
1e11ad30-1041-4520-10b0-8f9d30d30fcc -
UNII
9J765S329G -
RxCUI
892246 -
RxCUI
892251 -
RxCUI
892255 -
RxCUI
966158 -
RxCUI
966171 -
RxCUI
966185 -
RxCUI
966191 -
RxCUI
966201 -
RxCUI
966205 -
RxCUI
966218 -
RxCUI
966220 -
RxCUI
966221 -
RxCUI
966222 -
RxCUI
966224 -
RxCUI
966225 -
RxCUI
966247 -
RxCUI
966248 -
RxCUI
966249 -
RxCUI
966250 -
RxCUI
966251 -
RxCUI
966253 -
RxCUI
966270 -
RxCUI
966271 -
RxCUI
966282
What the source publishes
- Labeler
- AbbVie Inc.
- Active ingredients
- Levothyroxine Sodium
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Synthroid",
"splId": "b85ab7fa-ba96-43cd-b736-44b3924e644c",
"labels": [
{
"setId": "1e11ad30-1041-4520-10b0-8f9d30d30fcc",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e11ad30-1041-4520-10b0-8f9d30d30fcc",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1e11ad30-1041-4520-10b0-8f9d30d30fcc"
}
],
"routes": [
"ORAL"
],
"labeler": "AbbVie Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1000 TABLET in 1 BOTTLE (0074-4341-19)",
"package_ndc": "0074-4341-19",
"identifierStatus": "well-formed",
"marketing_start_date": "20020724"
},
{
"sample": true,
"description": "2 BLISTER PACK in 1 CARTON (0074-4341-72) / 7 TABLET in 1 BLISTER PACK",
"package_ndc": "0074-4341-72",
"identifierStatus": "well-formed",
"marketing_start_date": "20160603"
},
{
"sample": false,
"description": "90 TABLET in 1 BOTTLE (0074-4341-90)",
"package_ndc": "0074-4341-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20020724"
}
],
"productId": "0074-4341_b85ab7fa-ba96-43cd-b736-44b3924e644c",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "0074-4341",
"deaSchedule": null,
"genericName": "Levothyroxine Sodium",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "LEVOTHYROXINE SODIUM",
"strength": "25 ug/1"
}
],
"applicationNumber": "NDA021402",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20020724",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0300747149902",
"0300747068197",
"0300744341194",
"0300745182192",
"0300747070190",
"0300747069903",
"0300749296192",
"0300743727906",
"0300747148905",
"0300746624905"
],
"unii": [
"9J765S329G"
],
"rxcui": [
"892246",
"892251",
"892255",
"966158",
"966171",
"966185",
"966191",
"966201",
"966205",
"966218",
"966220",
"966221",
"966222",
"966224",
"966225",
"966247",
"966248",
"966249",
"966250",
"966251",
"966253",
"966270",
"966271",
"966282"
],
"spl_set_id": [
"1e11ad30-1041-4520-10b0-8f9d30d30fcc"
],
"manufacturer_name": [
"AbbVie Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0074-4341_b85ab7fa-ba96-43cd-b736-44b3924e644c"